To Top

Archives for: September 29th, 2015

Alpha-1 Patient Focused Drug Development Meeting

Written by Lisa Sencen on September 29, 2015

The purpose of this Patient-Focused Drug Development meeting is to obtain input on the symptoms and other impacts that matte most to patients with AATD. FDA also intends to seek patients’ perspectives on current approaches to treating this disorder. FDA expects that this information will come directly from patients, caregivers,… Read More